Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Cocrystal Pharma, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +1 vs. Q1 2026
- Shares held
- 1.11M
- +335.9K (+43.3%) vs. Q1 2026
- Total value
- $1.17M
- +$383.6K (+48.9%) vs. Q1 2026
- New holders
- 7
- 3 more added
- Sold out
- 6
- 7 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.17M |
| Q1 2026 | 26 | $783.8K |
| Q4 2025 | 28 | $754.3K |
| Q3 2025 | 22 | $831.3K |
| Q2 2025 | 22 | $1.02M |
| Q1 2025 | 24 | $1.06M |
| Q4 2024 | 24 | $1.44M |
| Q3 2024 | 20 | $1.27M |
| Q2 2024 | 14 | $1.57M |
| Q1 2024 | 16 | $1.18M |
| Q4 2023 | 17 | $1.28M |
| Q3 2023 | 16 | $1.32M |
| Q2 2023 | 20 | $1.59M |
| Q1 2023 | 21 | $1.47M |
| Q4 2022 | 21 | $2.08M |
| Q3 2022 | 27 | $3.99M |
| Q2 2022 | 33 | $5.83M |
| Q1 2022 | 34 | $7.90M |
| Q4 2021 | 35 | $9.78M |
| Q3 2021 | 41 | $16.1M |
| Q2 2021 | 42 | $25.0M |
| Q1 2021 | 35 | $13.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 358,228 | $376.1K | 0.00% | +118,257+49.3% | Added |
| Renaissance Technologies LLC | 179,628 | $188.6K | 0.00% | +55,700+44.9% | Added |
| Two Sigma Investments, LP | 175,379 | $184.1K | 0.00% | +175,379 | New |
| Geode Capital Management, LLC | 76,208 | $80.0K | 0.00% | −14,023−15.5% | Reduced |
| BlackRock, Inc. | 73,746 | $77.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 45,118 | $47.4K | 0.00% | +45,118 | New |
| Neuberger Berman Group LLC | 31,886 | $33.5K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 29,342 | $30.8K | 0.00% | −6,689−18.6% | Reduced |
| Jane Street Group, LLC | 25,761 | $27.0K | 0.00% | +13,050+102.7% | Added |
| Vanguard Fiduciary Trust Co | 24,016 | $25.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,543 | $21.6K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 20,336 | $21.0K | 0.00% | +20,336 | New |
| Parallel Advisors, LLC | 12,569 | $13.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,921 | $12.5K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 10,752 | $11.3K | 0.01% | +10,752 | New |
| Wells Fargo & Company | 6,257 | $6.57K | 0.00% | −782−11.1% | Reduced |
| UBS Group AG | 4,133 | $4.34K | 0.00% | −511−11.0% | Reduced |
| Tower Research Capital LLC (TRC) | 3,984 | $4.18K | 0.00% | −264−6.2% | Reduced |
| Morgan Stanley | 871 | $915 | 0.00% | −77−8.1% | Reduced |
| Northwestern Mutual Wealth Management Co | 817 | $858 | 0.00% | 00.0% | Unchanged |
| Clean Yield Group | 418 | $439 | 0.00% | 00.0% | Unchanged |
| NVWM, LLC | 84 | $88 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 42 | $44 | 0.00% | +42 | New |
| SBI Securities Co., Ltd. | 33 | $35 | 0.00% | 00.0% | Unchanged |
| Allied Private Wealth LLC | 32 | $31 | 0.00% | +32 | New |
| Vima LLC | 17 | $18 | 0.00% | +17 | New |
| Royal Bank of Canada | 9 | $0 | 0.00% | −42−82.4% | Reduced |
| FMR LLC | 0 | $0 | 0.00% | −334−100.0% | Sold out |
| T3 Companies, LLC | 0 | $0 | 0.00% | −51,500−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,255−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,080−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −237−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |